Back to trial details

Intake questionnaire

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Applying to Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital · Marietta, Georgia

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Extensive-Stage Small Cell Lung Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Marietta for study visits?